@incollection{,
	
					
					
					C84D58D2CA39CCB34DA0B887FC9170DD
				,
	author={{MajanNaim} and {N. I.Patel} and {AejazAhmed}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}2012739
}

@incollection{b0,
	
	
		,
	title={{A new method development and validation for analysis of rivaroxaban in formulation by RP-HPL}}
		,
	author={{
			KCSekhar
		} and {
			PSVani
		} and {
			DLakshami
		} and {
			CDevi
		}}
		
		
		
	
	
		,
	journal={{Res. Desk}}
		
			1
			1
			
			,
	year={2012}
		
	

}

@incollection{b1,
	
	
		,
	title={{Development of validated RP-HPLC method for estimation of rivaroxaban in pharmaceutical formulation}}
		,
	author={{
			VShivashankar
		} and {
			MGandhimathi
		} and {
			TKRavi
		}}
		
		
	
	
		,
	journal={{Int. J. Pharm and Anal. Res}}
		
			4
			4
			
			,
	year={2015}
		
	

}

@incollection{b2,
	
	
		,
	title={{Assay comparison of rivaroxaban by new HPLC method with an existing method in tablet dosage form}}
		,
	author={{
			SSahoo
		} and {
			SKMekap
		}}
		
	
	
		,
	journal={{Pharm. and Bio. Eva}}
		
			4
			3
			
			,
	year={2017}
		
	

}

@incollection{b3,
	
	
		,
	title={{A Novel RP-HPLC method for the quantification of rivaroxaban in formulation}}
		,
	author={{
			VBRao
		} and {
			BSReddy
		}}
		
	
	
		,
	journal={{Int. J. Pharm. and Bio. Sci}}
		
			4
			4
			
			,
	year={2013}
		
	

}

@incollection{b4,
	
	
		,
	title={{Simultaneous RP-HPLC method development and validation of clopidogrel and rivaroxaban in synthetic Mixture}}
		,
	author={{
			AMPrajapati
		} and {
			HAPatel
		}}
		
	
	
		,
	journal={{Int. J. Pharm}}
		
			5
			2
			
			,
	year={2015}
		
	

}

@incollection{b5,
	
	
		,
	title={{stress study and estimation of a potent anticoagulant drug rivaroxaban by a validated HPLC method: Technology transfer to UPLC}}
		,
	author={{
			HJebaliya
		} and {
			BDabhi
		} and {
			MJadeja
		} and {
			YShah
		} and {
			A
		}}
		
		
		
		
	
	
		,
	journal={{J. Chem. And. Pharm. Sci}}
		
			7
			10
			
			,
	year={2015}
		
	

}

@incollection{b6,
	
	
		,
	title={{Stability-indicating UPLC method for determining related substances and degradants in rivaroxaban}}
		,
	author={{
			PSRao
		} and {
			VKCholeti
		} and {
			VRReddy
		}}
		
		
	
	
		,
	journal={{Int. J. Res.and Pharm. Sci}}
		
			5
			2
			
			,
	year={2015}
		
	

}

@book{b7,
	
	
		,
	title={{Application of stability indicating HPLC method with CLP RIV}}
		,
	author={{
			BSSheshamamba
		} and {
			PVVenkata
		} and {
			CBSekaran
		}}
		
		
		
	

}

@book{b8,
	
	
		,
	title={{Drug profile for Rivaroxaban}}
		
		
			,
	year={August-2017}
		
	

}

@book{b9,
	
	
		,
	title={{Drug profile for Clopidogrel}}
		
		
			,
	year={August-2017}
		
	

}

@incollection{b10,
	
	
		,
	title={{}}
	
	
		,
	journal={{Chem. Sci. Tran}}
		
			3
			4
			
			,
	year={2014}
		
	

}

@incollection{b11,
	
	
		,
	title={{Development of a stability-indicating HPLC method and a dissolution test for rivaroxaban dosage forms}}
		,
	author={{
			ESouri
		} and {
			SMottaghi
		} and {
			MZargarpoor
		} and {
			RAhmadkhania
		}}
		
		
		
	
	
		,
	journal={{Acta.Chromat}}
		
			28
			3
			
			,
	year={2016}
		
	

}

@incollection{b12,
	
	
		,
	title={{Investigation of the profile and kinetics of degradation of rivaroxaban using HPLC, TLCdensitometry and LC/MS/MS: Application to preformulation studies}}
		,
	author={{
			MAAbdallah
		} and {
			Al-GhobasyMa
		} and {
			HMLotfy
		}}
		
		
	
	
		,
	journal={{Bill. Fac. Pharm}}
		
			
			,
	year={2015}
		
	

}

@incollection{b13,
	
	
		,
	title={{High performance thin layer chromatographic method with densitometry analysis for determination of rivaroxaban from its tablet dosage form}}
		,
	author={{
			DVaghela
		} and {
			PPatel
		}}
		
	
	
		,
	journal={{Int. J. Pharm. and Pharm. Sci}}
		
			6
			6
			
			,
	year={2014}
		
	

}

@incollection{b14,
	
	
		,
	title={{Development and validation of UV spectrophotometric method for the determination of rivaroxaban}}
		,
	author={{
			CBSekran
		} and {
			VHBind
		} and {
			MRDamayanthi
		} and {
			ASireesha
		}}
		
		
		
	
	
		,
	journal={{Der. Pharma chemical}}
		
			5
			4
			
			,
	year={2013}
		
	

}

@book{b15,
	
	
		,
	title={{}}
		,
	author={{
			PharmacopeialUsp30-Nf25
		} and {
			Forum
		}}
		
		
			32
			74
		
	

}

@incollection{b16,
	
	
		,
	title={{Validation of assay for bulk clopidogrel and for some tablet forms by reverse-phase highperformance liquid chromatography}}
		,
	author={{
			NKSahoo
		} and {
			MSahu
		} and {
			PSRao
		} and {
			JNIndira
		} and {
			SNRani
		} and {
			GKGhosh
		}}
		
		
		
		
		
	
	
		,
	journal={{J.Taib. Uni}}
		
			8
			
			,
	year={2014}
		
	

}

@incollection{b17,
	
	
		,
	title={{Development and validation of RP-HPLC method for the estimation of clopidogrel bisulphate}}
		,
	author={{
			DBhagat
		} and {
			VMannur
		} and {
			VMastiholimath
		}}
		
		
	
	
		,
	journal={{Mal. J. Anal. Sci}}
		
			17
			3
			
			,
	year={2013}
		
	

}

@incollection{b18,
	
	
		,
	title={{Development and validation of RP-HPLC method for determination of clopidogrel in tablets}}
		,
	author={{
			MAAmmar
		} and {
			SHaider
		} and {
			HMando
		}}
		
		
	
	
		,
	journal={{Int. J. Pharm. Sci. Rev. Res}}
		
			14
			2
			
			,
	year={2012}
		
	

}

@incollection{b19,
	
	
		,
	title={{method development and validation of clopidogrel bisulphate by reverse phase-HPLC in bulk and pharmaceutical dosage forms}}
		,
	author={{
			AMaunika
		} and {
			NSriram
		}}
		
	
	
		,
	journal={{Int. J. Pharm. and Anal. Res}}
		
			1
			1
			
			,
	year={2012}
		
	

}

@incollection{b20,
	
	
		,
	title={{Development and validation of stability indicating RP-HPLC method for the determination of clopidogrel bisulphate in bulk and its dosage forms}}
		,
	author={{
			VSKrishna
		} and {
			DRKumar
		} and {
			KBalamurlikrishna
		} and {
			CRambabu
		}}
		
		
		
	
	
		,
	journal={{Der. Pharm. Chem}}
		
			6
			2
			
			,
	year={2014}
		
	

}

@incollection{b21,
	
	
		,
	title={{Stability-indicating liquid chromategraphy for determination of clopidogrel bisulfate in tablets: Application to content uniformity testing}}
		,
	author={{
			NAAlarfaz
		}}
	
	
		,
	journal={{J. Saudi. Chem. Soc}}
		
			16
			
			,
	year={2012}
		
	

}

@incollection{b22,
	
	
		,
	title={{Micellar high performance liquid chromatographic determination of a binary mixture of rivaroxaban and clopidogrel and application to biological fluids}}
		,
	author={{
			HAAziz
		} and {
			FIbrahim
		} and {
			SEl-Din
		} and {
			MEFathy
		}}
		
		
		
	
	
		,
	journal={{Pharm. Anal. Acta}}
		
			7
			9
			,
	year={2016}
		
	

}

@incollection{b23,
	
	
		,
	title={{Simultaneous Rp-Hplc method development and validation of clopidogrel and rivaroxaban in synthetic mixture}}
		,
	author={{
			AMPrajapati
		} and {
			HAPatel
		}}
		
	
	
		,
	journal={{In.t J. Pharm}}
		
			5
			2
			
			,
	year={2015}
		
	

}

@incollection{b24,
	
	
		,
	title={{A validated RP-HPLC method for the simultaneous estimation of clopidogrel bisulfate and rivaroxaban in pharmaceutical application}}
		,
	author={{
			RSajjanwar
		} and {
			SBhashkaran
		} and {
			KKakati
		} and {
			SJKumar
		}}
		
		
		
	
	
		,
	journal={{Jour. of Appl. Pharm. Res}}
		
			3
			
			,
	year={2015}
		
	

}

@incollection{b25,
	
	
		,
	title={{How to approach a forced degradation study}}
		,
	author={{
			HBrummer
		}}
	
	
		,
	journal={{Life. Sci. Tech. Bul}}
		
			31
			
			,
	year={2011}
		
	

}